News about Diabetes

Newly discovered ‘molecular fingerprints’ could transform diabetes treatment and diagnosis

Unprecedented insights into insulin resistance could pave the way for better treatments and earlier detection of type 2 diabetes.

Anan Yaghmur is new Professor at IF

As of 1 April, Anan Yaghmur is Professor of Pharmaceutical Physical Chemistry, Self-Assembly Systems, here at the Department of Pharmacy, where he is a member of the Pharmaceutical Physical and Analytical Chemistry…

Metabolism Day 2025 - Some numbers and many thank yous

As interest in the conference has grown across the University, and beyond, we've sold out the impressive Jerne Auditorium for two straight years! Executive Director Juleen Zierath welcoming participants to Metabolis…

LEAP2: A new hormone with big implications for metabolism?

Often called the hunger hormone, ghrelin tells your brain you are hungry and increases your appetite. Another recently discovered hormone, LEAP2, prevents ghrelin from sending these signals, thereby lowering appetite.

Diabetes and hormone disorder research receives millions in funding

The Danish Diabetes and Endocrine Academy supports new research into diabetes and hormone-related research at SUND.

Many Greenlanders Face 10 Times Higher Risk of Diabetes – Exercise May Be Their Only Solution

A significant portion of the Greenlandic Inuit population carries a genetic variant that increases their risk of type 2 diabetes tenfold. Now, researchers from the University of Copenhagen have discovered that the key t…

Salivary biomarkers as a diagnostic tool in type 2 diabetes

The Deshmukh and Hansen Groups have identified distinct molecular and taxonomic signatures in saliva that are associated with type 2 diabetes (T2D).

New weight loss drug target burns energy and lowers appetite – without the nausea and vomiting

Scientists have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity.

Rethinking body mass index standards: Addressing hidden nutritional risks across populations

Current body mass index cut-offs may underestimate disease risk in certain populations, especially in South-East Asia, where a 'thin-fat' phenotype is prevalent.

Genetic study of insulin-releasing beta-cells presents promise for personalized diabetes treatments

An international team of scientists discover new genes and molecular pathways that influence the ability of beta cells to produce and release insulin.

A simple blood test warns of possible cardiometabolic complications for children with obesity

Scientists have detected lipid biomarkers in children and teenagers with obesity that indicate an increased risk of developing type 2 diabetes as adults.

Cone snail venom may improve treatment for hormonal disorders

Sea snails secrete hormone-like toxins causing extended insulin shock in its prey, new research from the University of Copenhagen concludes. The toxin may be used to improve treatment for hormonal disorders.

New research initiative is to shed light on the role of intestinal bacteria in obesity, diabetes, and cardiovascular diseases

A new research initiative, the Microbiome Health Initiative, will investigate whether there is a causal relationship between intestinal bacteria and conditions such as diabetes and cardiovascular diseases. The Departmen…

Global health crisis: Vietnam shows new ways to treat diabetes

Med øget fokus på uformel omsorg er det muligt at forbedre diabetespatienters liv markant. Det viser forskningsprojektet VALID, der netop har afsluttet sin første fase i Vietnam og kan få betydning andre steder.

A research agenda for continuity of chronic health care for forcibly displaced persons

On 14 September 2023, University of Copenhagen’s School of Global Health hosted a symposium on the topic of ‘Continuity of chronic healthcare among forcibly displaced persons’.

Call for young innovators: Urban Health Case Challenge in Warsaw, Poland

Are you interested in creating innovative solutions against obesity in urban environments? Be one of the ten UCPH students to compete in the Urban Health Case Challenge in Warsaw, Poland on December 9-12, 2023.

Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes

Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie burning and increases insulin sensitivity. The spinout Embark Biotech has now been acquired by Novo Nordisk

Novo Nordisk køber CBMR-spinoff og ny metode til at behandle fedme og type 2-diabetes

Grundforskere fra Københavns Universitet har opdaget et nyt lægemiddelmål, som hæmmer appetitten, øger kroppens kalorieforbrænding og insulinfølsomhed. Novo Nordisk købt forskernes spinoffselskab, Embark Biotech.

Mysterious hormone makes insulin work better

It makes animals want to eat less and is found in levels 100 times greater in pregnant women. A new study from the University of Copenhagen also reports that it makes insulin work better in rodents. While its role in ou…

Children born from mothers with malaria have a higher risk of developing diabetes

New research from University of Copenhagen have found that babies born from mothers with malaria have a higher risk of developing diabetes as well as other cardio-metabolic diseases.

Medical treatment of fatty liver may be possible thanks to omega-3 fatty acid nanoparticles

Non-alcoholic fatty liver is a widespread disease because of the common occurrences of obesity and type-2 diabetes in Europe, particularly in Denmark.

New affiliated professor in arctic health at University of Copenhagen

University of Copenhagen is appointing medical doctor Michael Lynge Pedersen as the new affiliated professor in artic health at the Department of Public Health.

CBMR secures five-year funding extension from Novo Nordisk Foundation

Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.

Patients with cancer respond poorly to the hormone insulin

Associate Professor at the Department of Biomedical Sciences, Lykke Sylow, has published a new meta-study showing that cancer patients are at increased risk of metabolic dysfunction.